Glutamate Receptor Ion Channels: Structure, Regulation, and Function

Pharmacological Reviews - Tập 62 Số 3 - Trang 405-496 - 2010
Stephen F. Traynelis1,2,3,4, Lonnie P. Wollmuth1,2,3,4, Chris J. McBain1,2,3,4, Frank S. Menniti1,2,3,4, Katie M. Vance1,2,3,4, Kevin K. Ogden1,2,3,4, Kasper B. Hansen1,2,3,4, Hongjie Yuan1,2,3,4, Scott J. Myers1,2,3,4, Raymond Dingledine1,2,3,4
1Department of Neurobiology and Behavior & Center for Nervous System Disorders, Stony Brook University, Stony Brook, New York (L.P.W.)
2Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia (S.F.T., K.M.V., K.K.O., K.B.H., H.Y., S.J.M., R.D.)
3Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland (C.J.M.)
4cyclicM LLC, Mystic, Connecticut (F.S.M.)

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1016/j.biopsych.2009.08.038

10.1016/S1474-4422(09)70146-2

10.1038/nature03010

10.1111/j.1460-9568.2005.04340.x

10.1074/jbc.M909883199

10.1177/0091270009336735

10.1523/JNEUROSCI.0325-07.2007

10.1021/bi900107m

10.1016/S0896-6273(02)00674-8

10.1016/0896-6273(89)90310-3

Akins, 2002, Glutamate AMPA receptor antagonist treatment for ischaemic stroke, Curr Med Res Opin, 18, s9, 10.1185/030079902125000660

10.1038/nsmb.1531

10.1001/jama.286.21.2673

10.1016/j.neuropharm.2003.11.026

10.1016/0014-2999(96)00399-8

10.1177/026988110001400101

10.1006/geno.2001.6666

Anson, 1998, Identification of amino acid residues of the NR2A subunit that control glutamate potency in recombinant NR1/NR2A NMDA receptors, J Neurosci, 18, 581, 10.1523/JNEUROSCI.18-02-00581.1998

10.1113/jphysiol.1996.sp021394

10.1073/pnas.96.25.14571

10.1038/2167

10.1124/jpet.104.077172

10.1016/0306-4522(96)00263-1

10.1016/0006-8993(94)90669-6

10.2174/138945007780618490

10.1124/mol.58.4.802

10.1124/jpet.102.040360

10.1097/00001756-200503150-00017

10.1016/S0006-3495(02)75430-1

10.1016/S0896-6273(00)00094-5

10.1016/j.cell.2006.08.037

10.1073/pnas.1037393100

10.1038/27692

Ascher, 1988, N-methyl-d-aspartate-activated channels of mouse central neurones in magnesium-free solutions, J Physiol, 399, 207, 10.1113/jphysiol.1988.sp017076

10.1113/jphysiol.1988.sp017078

Ashby MC Daw MI Isaac JTR (2008) AMPA receptors, in The Glutamate Receptors ( Gereau RW Swanson GT eds) pp 1–44, Humana Press, Totowa, NJ.

10.1016/j.str.2007.10.012

10.1074/jbc.M702778200

10.1111/j.1460-9568.1994.tb00572.x

10.1523/JNEUROSCI.1471-05.2005

10.1016/S0304-3940(97)13422-X

10.1046/j.1471-4159.2003.02048.x

10.1124/mol.106.030700

10.1016/S0896-6273(01)00333-6

10.1074/jbc.M408413200

10.1111/j.1469-7793.1997.575bj.x

10.1111/j.1469-7793.1998.635bm.x

Bai, 1993, Cloning and analysis of the 5′-flanking sequence of the rat N-methyl-d-aspartate receptor 1 (NMDAR1) gene, Biochim Biophys Acta, 1152, 197, 10.1016/0005-2736(93)90249-Y

10.1074/jbc.270.13.7737

10.1074/jbc.272.9.5936

10.1074/jbc.273.2.1086

10.1046/j.1471-4159.2003.01922.x

10.1023/A:1027380315902

10.1073/pnas.0809442106

10.1016/j.neuron.2005.09.024

10.1113/jphysiol.1988.sp016961

10.1021/pr0701254

10.1177/1073858408324788

10.1523/JNEUROSCI.5137-07.2008

Banke, 2000, Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase, J Neurosci, 20, 89, 10.1523/JNEUROSCI.20-01-00089.2000

10.1523/JNEUROSCI.3154-04.2005

Banke, 2001, Identification of amino acid residues in GluR1 responsible for ligand binding and desensitization, J Neurosci, 21, 3052, 10.1523/JNEUROSCI.21-09-03052.2001

10.1002/(SICI)1097-4547(19970715)49:2<176::AID-JNR6>3.0.CO;2-6

10.1038/nn1000

10.1523/JNEUROSCI.0827-05.2005

10.1523/JNEUROSCI.1204-08.2008

10.1159/000015558

10.1016/S0378-1119(01)00611-4

10.1074/jbc.272.52.32727

10.1016/S0896-6273(02)00776-6

10.1016/j.neuron.2005.08.034

10.1016/j.bmcl.2004.05.053

10.1038/85070

10.1016/j.eplepsyres.2003.12.010

10.1146/annurev.biochem.71.110601.135501

10.1038/mp.2008.130

10.1016/j.neuron.2007.01.030

10.1016/S0028-3908(00)00195-7

Baumbarger, 2001, Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator, J Pharmacol Exp Ther, 298, 86

10.1111/j.1742-4658.2008.06517.x

10.1038/35081080

10.1016/S0896-6273(00)80710-2

10.1074/jbc.M600679200

10.1126/science.8391168

10.1016/j.pain.2008.12.003

10.1016/j.neuron.2007.07.035

10.1245/ASO.2003.08.007

Ben-Abraham, 2000, Dextromethorphan in chronic pain: a disappointing update, Isr Med Assoc J, 2, 708

10.1016/j.neulet.2004.11.064

10.1038/31709

10.1016/0896-6273(95)90293-7

10.1111/j.1471-4159.1989.tb07243.x

10.1113/jphysiol.1990.sp018215

Benveniste, 1995, Trapping of glutamate and glycine during open channel block of rat hippocampal neuron NMDA receptors by 9-aminoacridine, J Physiol, 483, 367, 10.1113/jphysiol.1995.sp020591

10.1038/sj.npp.1300559

10.1111/j.1471-4159.2006.04253.x

10.1016/S0006-3223(99)00230-9

10.1089/cap.2006.16.525

10.1016/0306-4522(96)00157-1

10.1016/S0006-8993(97)01365-6

10.1016/S0006-8993(98)00067-5

10.1016/0014-2999(88)90367-6

10.1016/S0166-2236(02)02259-2

10.1021/jm020588f

10.1097/00001756-200404090-00037

Blanpied, 1997, Trapping channel block of NMDA-activated responses by amantadine and memantine, J Neurophysiol, 77, 309, 10.1152/jn.1997.77.1.309

10.1523/JNEUROSCI.4262-04.2005

10.1073/pnas.90.14.6528

10.1016/S0028-3908(96)00156-6

10.2174/1381612024607108

10.1016/S0028-3908(98)00139-7

10.1016/S0014-2999(99)00478-1

10.1016/j.conb.2007.04.003

10.1113/jphysiol.2007.148353

10.1016/j.neuron.2006.06.013

10.1242/dev.02219

10.1046/j.1471-4159.2003.01956.x

10.1016/j.neuropharm.2005.02.007

10.1074/jbc.M009105200

Borges, 2003, Activity of the rat GluR4 promoter in transfected cortical neurons and glia, J Neurochem, 86, 1162, 10.1046/j.1471-4159.2003.01926.x

10.1038/46290

10.1021/jm060420k

10.1016/j.bmcl.2006.06.002

10.1113/jphysiol.2001.013407

10.1113/jphysiol.2002.033076

Bowie, 1998, Activity-dependent modulation of glutamate receptors by polyamines, J Neurosci, 18, 8175, 10.1523/JNEUROSCI.18-20-08175.1998

10.1016/0896-6273(95)90049-7

Bowlby, 1993, Pregnenolone sulfate potentiation of N-methyl-d-aspartate receptor channels in hippocampal neurons, Mol Pharmacol, 43, 813

10.1016/S0028-3908(98)00218-4

Brackley, 1993, Selective antagonism of native and cloned kainate and NMDA receptors by polyamine-containing toxins, J Pharmacol Exp Ther, 266, 1573

10.1111/j.1460-9568.2003.03054.x

Brauneis, 1996, Differential sensitivity of recombinant N-methyl-d-aspartate receptor subunits to inhibition by dynorphin, J Pharmacol Exp Ther, 279, 1063

10.1021/jm0204441

Bresink, 1996, Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells, Br J Pharmacol, 119, 195, 10.1111/j.1476-5381.1996.tb15971.x

Brickley, 2003, NR2B and NR2D subunits coassemble in cerebellar Golgi cells to form a distinct NMDA receptor subtype restricted to extrasynaptic sites, J Neurosci, 23, 4958, 10.1523/JNEUROSCI.23-12-04958.2003

Bridges, 2008, Design of potent GlyT1 inhibitors: in vitro and in vivo profiles, Curr Opin Mol Ther, 10, 591

10.1073/pnas.94.20.11019

10.1113/jphysiol.2007.144618

Bruening-Wright, 2002, Localization of the activation gate for small conductance Ca2+-activated K+ channels, J Neurosci, 22, 6499, 10.1523/JNEUROSCI.22-15-06499.2002

10.1176/appi.ajp.2007.06081358

Buller, 1994, The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition, J Neurosci, 14, 5471, 10.1523/JNEUROSCI.14-09-05471.1994

10.1016/j.ejphar.2009.03.011

10.1002/med.20133

10.1124/jpet.109.158543

10.1016/0896-6273(92)90120-3

10.1126/science.1382314

10.1113/jphysiol.1996.sp021674

10.1113/jphysiol.1995.sp020738

10.1007/BF02088679

10.1016/S0960-894X(03)00232-4

Calderone, 2003, Ischemic insults derepress the gene silencer REST in neurons destined to die, J Neurosci, 23, 2112, 10.1523/JNEUROSCI.23-06-02112.2003

10.1021/jm015552m

10.1111/j.1460-9568.2007.05431.x

10.1016/j.ceca.2006.08.021

10.1163/15685600038189

Carvalho, 1999, Characterization of phosphorylation sites on the glutamate receptor 4 subunit of the AMPA receptors, J Neurosci, 19, 4748, 10.1523/JNEUROSCI.19-12-04748.1999

10.1111/j.1469-7793.1998.317bb.x

10.1038/40645

10.1242/jcs.004200

10.1002/med.20084

Cathala, 2000, Developmental profile of the changing properties of NMDA receptors at cerebellar mossy fiber-granule cell synapses, J Neurosci, 20, 5899, 10.1523/JNEUROSCI.20-16-05899.2000

10.1016/S0143-4179(98)90022-1

10.1007/s12035-008-8029-9

10.1016/S0028-3908(00)00197-0

10.1002/(SICI)1097-4547(19990801)57:3<315::AID-JNR3>3.0.CO;2-#

10.1523/JNEUROSCI.3485-07.2008

10.1124/mol.51.5.861

10.1212/01.wnl.0000260240.46070.7c

Chappell, 2002, A crossover, add-on trial of talampanel in patients with refractory partial seizures, Neurology, 58, 1680, 10.1212/WNL.58.11.1680

10.1038/nature715

10.1073/pnas.0904175106

10.1038/nature05123

10.2174/0929867043456061

10.3109/09687689509072435

Chazot, 1994, Molecular characterization of N-methyl-d-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule, J Biol Chem, 269, 24403, 10.1016/S0021-9258(19)51098-5

10.1016/S0028-3908(01)00191-5

Chazot, 1997, Molecular dissection of native mammalian forebrain NMDA receptors containing the NR1 C2 exon: direct demonstration of NMDA receptors comprising NR1, NR2A, and NR2B subunits within the same complex, J Neurochem, 69, 2138, 10.1046/j.1471-4159.1997.69052138.x

Cheffings, 2000, Single channel analysis of a novel NMDA channel from Xenopus oocytes expressing recombinant NR1a, NR2A and NR2D subunits, J Physiol, 526, 481

10.1074/jbc.M513029200

10.1016/j.neuron.2009.04.015

10.1038/45568

10.1113/jphysiol.1997.sp021909

10.1124/jpet.105.085142

10.1111/j.1471-4159.2006.03991.x

10.1038/35050030

10.1124/mol.64.3.703

Chen, 1998, Dynorphin block of N-methyl-d-aspartate channels increases with the peptide length, J Pharmacol Exp Ther, 284, 826

10.1124/mol.65.1.157

Chen, 1999, Subtype-dependence of NMDA receptor channel open probability, J Neurosci, 19, 6844, 10.1523/JNEUROSCI.19-16-06844.1999

10.1124/mol.51.6.1015

10.1124/mol.59.2.212

10.1113/jphysiol.2007.143172

10.1124/mol.104.008185

10.1016/j.neuropharm.2006.07.003

10.1021/jm00016a017

Chenard, 1999, Antagonists selective for NMDA receptors containing the NR2B subunit, Curr Pharm Des, 5, 381, 10.2174/138161280504230110102541

10.1038/nchembio738

10.1016/0166-2236(92)90191-A

Chetkovich, 2002, Phosphorylation of the postsynaptic density-95 (PSD-95)/discs large/zona occludens-1 binding site of stargazin regulates binding to PSD-95 and synaptic targeting of AMPA receptors, J Neurosci, 22, 5791, 10.1523/JNEUROSCI.22-14-05791.2002

10.1046/j.1471-4159.2001.00433.x

Chew, 1997, Growth factor-induced transcription of GluR1 increases functional AMPA receptor density in glial progenitor cells, J Neurosci, 17, 227, 10.1523/JNEUROSCI.17-01-00227.1997

10.1074/jbc.274.41.29366

10.1074/jbc.M101895200

10.1016/S0165-6147(00)01863-0

10.1016/0166-2236(95)93870-4

Choi, 2001, Three pairs of cysteine residues mediate both redox and Zn2+ modulation of the NMDA receptor, J Neurosci, 21, 392, 10.1523/JNEUROSCI.21-02-00392.2001

10.1016/S0896-6273(00)80763-1

10.1007/PL00000638

10.1038/71090

10.1038/sj.bjp.0703298

10.1016/0896-6273(90)90086-U

10.1523/JNEUROSCI.2156-04.2004

10.1124/jpet.103.062794

Chu, 1995, Ethanol inhibition of recombinant heteromeric NMDA channels in the presence and absence of modulators, J Neurochem, 65, 140, 10.1046/j.1471-4159.1995.65010140.x

10.1073/pnas.182412499

10.1523/JNEUROSCI.0546-04.2004

Chung, 2000, Phosphorylation of the AMPA receptor subunit GluR2 differentially regulates its interaction with PDZ domain-containing proteins, J Neurosci, 20, 7258, 10.1523/JNEUROSCI.20-19-07258.2000

Ciabarra, 1995, Cloning and characterization of χ-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family, J Neurosci, 15, 6498, 10.1523/JNEUROSCI.15-10-06498.1995

10.1016/S0140-6736(09)60046-5

10.1038/sj.npp.1301559

10.1016/S0960-894X(02)01061-2

10.1016/0306-4522(90)90261-2

10.1038/39315

10.1523/JNEUROSCI.0577-06.2006

10.1113/jphysiol.2008.160622

10.1021/jm800025e

10.1016/j.jmb.2009.07.082

10.1016/j.neuron.2006.01.019

10.1146/annurev.cellbio.24.110707.175235

10.1016/j.neuropharm.2008.02.012

Coleman, 2003, Surface expression of GluR-D AMPA receptor is dependent on an interaction between its C-terminal domain and a 4.1 protein, J Neurosci, 23, 798, 10.1523/JNEUROSCI.23-03-00798.2003

10.1038/nrn1556

10.1016/j.neuropharm.2008.06.063

Contractor A Swanson GT (2008) Kainate receptors, in The Glutamate Receptors ( Gereau RW Swanson GT eds) pp 99–158, Humana Press, Totowa, NJ.

10.1016/j.neuroscience.2009.01.004

10.1111/j.1471-4159.1992.tb11329.x

Coquelle, 2000, Agonist discrimination between AMPA receptor subtypes, Neuroreport, 11, 2643, 10.1097/00001756-200008210-00008

10.1074/jbc.M205587200

10.1016/S0896-6273(02)00753-5

10.1038/2185

10.1124/jpet.109.156752

10.1016/S0028-3908(99)00105-7

Coussen, 2002, Recruitment of the kainate receptor subunit glutamate receptor 6 by cadherin/catenin complexes, J Neurosci, 22, 6426, 10.1523/JNEUROSCI.22-15-06426.2002

10.1016/j.neuron.2005.06.033

10.1006/nbdi.1997.0153

10.1073/pnas.0813321106

10.1007/s00213-003-1720-7

10.1002/hipo.20078

Crosby, 2003, Amantadine in Parkinson's disease, Cochrane Database Syst Rev, 2003, CD003468

Crosby, 2003, Amantadine for dyskinesia in Parkinson's disease, Cochrane Database Syst Rev, 2003, CD003467

10.1016/S0960-894X(02)01060-0

10.1016/S0092-8674(00)00197-5

10.1369/jhc.4R6460.2005

Danysz, 2002, CX-516 Cortex pharmaceuticals, Curr Opin Investig Drugs, 3, 1081

10.1080/10298420290015872

10.1007/BF03033787

10.1016/j.neuropharm.2008.08.016

10.1073/pnas.1000838107

10.1038/30748

10.1111/j.1471-4159.1981.tb01736.x

10.1016/0006-8993(86)90127-7

10.1523/JNEUROSCI.0150-06.2006

10.1016/S0006-8993(00)03269-8

Dawson, 1990, Homomeric GluR1 excitatory amino acid receptors expressed in Xenopus oocytes, Mol Pharmacol, 38, 779

10.1097/00000542-200004000-00024

10.1016/S0896-6273(01)00487-1

10.1074/jbc.C300105200

10.1073/pnas.96.6.3269

10.1038/nrn2055

10.1074/jbc.M203032200

10.1016/S0960-894X(96)00547-1

10.1016/j.neuropharm.2009.05.010

10.1016/S0028-3908(98)00230-5

10.1016/S0014-2999(99)00280-0

10.1111/j.1471-4159.2009.05929.x

10.1074/jbc.M707587200

10.1523/JNEUROSCI.3704-08.2009

10.1097/01.anes.0000287061.77674.71

Dingledine, 1999, The glutamate receptor ion channels, Pharmacol Rev, 51, 7

Dingledine, 1992, Structural determinants of barium permeation and rectification in non-NMDA glutamate receptor channels, J Neurosci, 12, 4080, 10.1523/JNEUROSCI.12-10-04080.1992

10.1016/S0166-2236(99)01401-0

10.1007/BF01243418

Do, 1986, In vitro release and electrophysiological effects in situ of homocysteic acid, an endogenous N-methyl-(D)-aspartic acid agonist, in the mammalian striatum, J Neurosci, 6, 2226, 10.1523/JNEUROSCI.06-08-02226.1986

10.1021/jm061041u

10.1021/jm051086f

10.1021/jm050584l

Donevan, 1998, The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors, J Pharmacol Exp Ther, 285, 539

10.1016/S0306-4522(98)00109-2

10.1038/386279a0

Dong, 1999, Characterization of the glutamate receptor-interacting proteins GRIP1 and GRIP2, J Neurosci, 19, 6930, 10.1523/JNEUROSCI.19-16-06930.1999

Doody, 2004, Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease, Dement Geriatr Cogn Disord, 18, 227, 10.1159/000079833

10.1097/00008506-200401000-00019

10.1126/science.280.5360.69

10.1016/j.neuropharm.2008.01.005

10.1523/JNEUROSCI.5390-09.2010

10.1113/jphysiol.2006.124958

10.1113/jphysiol.2008.158634

10.1016/S0006-8993(96)01439-4

10.1074/jbc.C400590200

10.1124/mol.53.3.429

10.1046/j.1471-4159.2003.02062.x

Dunah, 1998, Developmental regulation of tyrosine phosphorylation of the NR2D NMDA glutamate receptor subunit in rat central nervous system, J Neurochem, 71, 1926, 10.1046/j.1471-4159.1998.71051926.x

10.1016/j.cacc.2009.07.010

10.1073/pnas.90.14.6731

10.1161/01.STR.30.10.2038

10.1146/annurev.ph.57.030195.002431

10.1038/351745a0

10.1073/pnas.90.2.755

Ehlers, 1998, Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments, J Neurosci, 18, 720, 10.1523/JNEUROSCI.18-02-00720.1998

10.1016/S0092-8674(00)81052-1

10.1016/j.brainres.2006.02.080

10.1016/S0304-3940(01)02524-1

10.1016/j.physbeh.2007.05.026

10.1016/j.bbrc.2007.06.179

10.1615/CritRevNeurobiol.v16.i3.10

10.1113/jphysiol.2004.080028

10.1523/JNEUROSCI.1613-05.2005

10.1124/mol.107.037333

10.1113/jphysiol.2005.095497

10.1113/jphysiol.2007.143941

10.1523/JNEUROSCI.1618-08.2008

10.1038/nn997

Evans, 1981, The effects of a series of omega-phosphonic alpha-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations, Br J Pharmacol, 75, 65, 10.1111/j.1476-5381.1982.tb08758.x

Everts, 1999, Lectin-induced inhibition of desensitization of the kainate receptor GluR6 depends on the activation state and can be mediated by a single native or ectopic N-linked carbohydrate side chain, J Neurosci, 19, 916, 10.1523/JNEUROSCI.19-03-00916.1999

10.1124/mol.52.5.861

10.1111/j.1460-9568.2004.03772.x

10.1113/jphysiol.2005.103580

10.1016/S0896-6273(00)81070-3

10.1016/j.neuropharm.2004.11.004

10.1038/sj.bjp.0705644

10.1016/j.neuron.2009.08.010

10.1074/jbc.M407069200

10.1016/S0006-3495(96)79274-3

10.1001/jama.298.3.330

10.1523/JNEUROSCI.2973-04.2004

10.1113/jphysiol.2004.077412

Fischer, 1997, Ro 25-6981, a highly potent and selective blocker of N-methyl-d-aspartate receptors containing the NR2B subunit, J Pharmacol Exp Ther, 283, 1285

10.1161/01.STR.0000255951.37434.aa

Fleck, 2003, Amino-acid residues involved in glutamate receptor 6 kainate receptor gating and desensitization, J Neurosci, 23, 1219, 10.1523/JNEUROSCI.23-04-01219.2003

Fleck, 1993, Aspartate and glutamate mediate excitatory synaptic transmission in area CA1 of the hippocampus, J Neurosci, 13, 3944, 10.1523/JNEUROSCI.13-09-03944.1993

10.1016/S0896-6273(01)00324-5

10.1523/JNEUROSCI.0477-04.2004

Follett, 2000, NBQX attenuates excitotoxic injury in developing white matter, J Neurosci, 20, 9235, 10.1523/JNEUROSCI.20-24-09235.2000

10.1111/j.1365-2125.2007.02880.x

10.1124/mol.104.002931

10.1038/24525

10.1016/S0074-7742(08)60279-2

10.1038/2194

10.1016/j.neuropharm.2009.03.002

10.1124/mol.106.024042

10.1074/jbc.M808547200

10.1113/jphysiol.2004.079467

10.1083/jcb.200501121

10.1097/00001756-200101220-00040

10.1016/S0304-3940(03)00805-X

10.1093/emboj/cdg303

10.1038/nature04089

10.4049/jimmunol.166.3.1433

10.1016/j.pain.2005.03.004

10.1074/jbc.271.16.9603

Gallo, 1992, Molecular cloning and development analysis of a new glutamate receptor subunit isoform in cerebellum, J Neurosci, 12, 1010, 10.1523/JNEUROSCI.12-03-01010.1992

10.1016/S0165-6147(00)01494-2

10.1016/S0896-6273(00)80590-5

Gardoni, 1998, Calcium/calmodulin-dependent protein kinase II is associated with NR2A/B subunits of NMDA receptor in postsynaptic densities, J Neurochem, 71, 1733, 10.1046/j.1471-4159.1998.71041733.x

10.7326/0003-4819-149-10-200811180-00008

10.1074/jbc.M504108200

10.1007/s12640-009-9003-7

10.1016/j.neuint.2007.07.003

10.1006/geno.1999.6032

10.1016/S0896-6273(00)80339-6

10.1098/rspb.1991.0007

10.1016/S1087-0792(02)90235-2

10.1016/j.neuron.2007.11.021

10.1038/nature07993

10.1016/0006-8993(90)91276-M

10.1021/bi8013196

10.1074/jbc.M900510200

Gill, 1994, The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia, Cerebrovasc Brain Metab Rev, 6, 225

10.1124/jpet.102.034322

10.1067/mcp.2000.108677

Gingrich, 2000, Potentiation of NMDA receptor function by the serine protease thrombin, J Neurosci, 20, 4582, 10.1523/JNEUROSCI.20-12-04582.2000

10.1021/jm0210008

10.1161/01.STR.0000025518.34157.51

10.1016/S0169-328X(99)00100-X

10.1016/j.schres.2008.08.012

10.1038/sj.npp.1301444

10.1097/00004714-200110000-00005

10.1001/archpsyc.56.1.21

10.1016/j.coph.2005.11.001

10.1523/JNEUROSCI.1237-07.2007

10.1111/j.1600-0854.2006.00521.x

10.1074/jbc.M512524200

10.1038/sj.bjp.0706199

10.1021/bi800690b

Gotti, 1988, Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia, J Pharmacol Exp Ther, 247, 1211

10.1113/jphysiol.2003.054320

10.1046/j.1440-1681.2002.03767.x

10.1038/sj.bjp.0707594

10.1046/j.0953-816x.2001.01790.x

10.1124/mol.61.2.326

10.1001/archneur.1991.00530210109030

10.1002/hipo.1072

10.1016/j.neuropharm.2006.02.013

10.1016/j.neuron.2006.05.020

10.1016/S0896-6273(02)00693-1

10.1016/S0896-6273(03)00668-8

10.1523/JNEUROSCI.0472-06.2006

10.1046/j.1460-9568.2003.02531.x

10.1016/S0028-3908(03)00274-0

10.1038/381793a0

10.1016/S0169-328X(03)00083-4

10.1016/0304-3940(92)90796-A

10.1046/j.1471-4159.2001.00493.x

10.1124/jpet.102.036962

10.1074/jbc.M700137200

10.1016/j.pharmthera.2004.04.001

10.1016/j.neuropharm.2008.10.008

10.1016/0014-2999(92)90140-Y

10.1111/j.1471-4159.2008.05729.x

Hansen, 2005, Tweaking agonist efficacy at N-methyl-d-aspartate receptors by site-directed mutagenesis, Mol Pharmacol, 68, 1510, 10.1124/mol.105.014795

10.1124/jpet.110.166256

10.1523/JNEUROSCI.4081-08.2009

10.1016/j.conb.2007.03.014

10.7326/0003-4819-143-6-200509200-00006

10.1113/jphysiol.2006.109603

10.1016/S0920-1211(99)00108-4

Hashimoto, 1999, Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer, J Neurosci, 19, 6027, 10.1523/JNEUROSCI.19-14-06027.1999

10.1016/j.neuron.2005.03.005

10.1074/jbc.M402599200

10.1523/JNEUROSCI.0799-04.2004

10.1016/j.neuron.2005.06.035

10.1016/j.neuron.2009.08.017

10.1016/S0006-3495(96)79375-X

Hennegriff, 1997, Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators, J Neurochem, 68, 2424, 10.1046/j.1471-4159.1997.68062424.x

10.1016/0896-6273(92)90098-X

10.1017/S1461145700001978

10.1016/0896-6273(93)90061-U

10.1523/JNEUROSCI.6063-08.2009

Hess, 1996, Cloning and functional characterization of human heteromeric N-methyl-d-aspartate receptors, J Pharmacol Exp Ther, 278, 808

Hess, 1998, Functional characterization of human N-methyl-d-aspartate subtype 1A/2D receptors, J Neurochem, 70, 1269, 10.1046/j.1471-4159.1998.70031269.x

Hille B (2001) Ion Channels of Excitable Membranes, 3rd ed. Sinauer Associates, Inc., Sunderland, MA.

10.1016/S0168-0102(99)00061-9

Hirano, 2003, Imaging of L-glutamate fluxes in mouse brain slices based on an enzyme-based membrane combined with a difference-image analysis, Anal Chem, 75, 3775, 10.1021/ac030088+

10.1074/jbc.273.33.21105

10.1016/S0896-6273(02)01191-1

10.1074/jbc.C200112200

Hiroi, 1998, Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures, J Neurosci, 18, 6952, 10.1523/JNEUROSCI.18-17-06952.1998

10.1074/jbc.M909302199

10.1523/JNEUROSCI.2671-07.2007

10.1213/01.ANE.0000086618.28845.9B

10.1021/jo0513865

10.1016/j.mcn.2006.08.006

10.1001/archpsyc.63.3.298

10.1021/jm020989v

10.1016/S0022-2836(02)00650-2

10.1038/342643a0

10.1016/0896-6273(94)90419-7

10.1073/pnas.0505522102

Hoo, 1994, Functional expression and pharmacological characterization of the human EAA4 (GluR6) glutamate receptor: a kainate selective channel subunit, Recept Channels, 2, 327

10.1016/0304-3940(89)90379-0

10.1016/j.neuroscience.2005.08.058

10.1074/jbc.M807050200

10.2174/1874241600902010016

10.1016/S0896-6273(04)00018-2

Howe, 1996, Homomeric and heteromeric ion channels formed from the kainate-type subunits GluR6 and KA2 have very small, but different, unitary conductances, J Neurophysiol, 76, 510, 10.1152/jn.1996.76.1.510

10.1016/j.nurt.2006.11.001

10.2174/1566524043479248

10.1038/35005118

10.1124/jpet.104.080168

10.1074/jbc.272.13.8618

10.1016/j.bbrc.2009.03.015

Huang, 2002, Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus, J Neurosci, 22, 8422, 10.1523/JNEUROSCI.22-19-08422.2002

10.1038/13165

10.1101/gad.1053003

10.1093/emboj/21.9.2139

10.1038/sj.emboj.7601322

10.1126/science.288.5469.1254

10.1016/0896-6273(90)90163-A

10.1073/pnas.85.4.1307

10.1126/science.1653450

10.1038/76615

Igarashi, 1997, Benzyl-polyamines: novel, potent N-methyl-d-aspartate receptor antagonists, J Pharmacol Exp Ther, 283, 533

Ihle, 2000, Modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor desensitization by extracellular protons, Mol Pharmacol, 58, 1204, 10.1124/mol.58.6.1204

10.1073/pnas.0805574105

10.1007/s002329900166

10.1016/0014-5793(92)81178-O

10.1016/S0168-0102(01)00277-2

10.1016/S1474-4422(02)00164-3

Ilyin, 1996, Subtype-selective inhibition of N-methyl-d-aspartate receptors by haloperidol, Mol Pharmacol, 50, 1541

10.1016/j.neuron.2005.05.022

10.1006/exnr.1997.6581

10.1176/appi.ajp.163.1.5

10.1124/mol.109.060343

10.1111/j.1471-4159.2009.05992.x

10.1016/0896-6273(95)90046-2

10.1016/j.neuron.2007.06.001

Ishii, 1993, Molecular characterization of the family of the N-methyl-d-aspartate receptor subunits, J Biol Chem, 268, 2836, 10.1016/S0021-9258(18)53849-7

10.1113/jphysiol.1990.sp018081

10.1021/pr0503578

10.1021/jm9702387

10.1016/j.neuropharm.2008.08.023

10.1073/pnas.0401838101

10.1113/jphysiol.2002.034413

10.1113/jphysiol.2001.012897

10.1016/S0074-7742(06)78003-5

10.1016/j.biopsych.2007.09.017

Javitt, 2009, Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification, Curr Opin Drug Discov Devel, 12, 468

10.1176/ajp.148.10.1301

Jenkins MA Kristensen AS Traynelis SF (2010) Stargazin and the GluA1 C-terminus influence the effects of CamKII-mediated phosphorylation on AMPA-R conductance, at the 54th Annual Meeting of the Biophysical Society; 2010 Feb 20–24; San Francisco, CA. Poster L-220. Biophysical Society, Bethesda, MD.

10.1021/jm070532r

10.1016/j.neulet.2006.04.027

10.1016/S0896-6273(00)80225-1

10.1038/417523a

10.1124/jpet.106.110528

10.1038/nn1091

10.1523/JNEUROSCI.2567-05.2005

10.1021/bi020632t

10.1021/bi020583k

10.1038/emboj.2009.140

Jo, 1999, Characterization of MALS/Velis-1, -2, and -3: a family of mammalian LIN-7 homologs enriched at brain synapses in association with the postsynaptic density-95/NMDA receptor postsynaptic complex, J Neurosci, 19, 4189, 10.1523/JNEUROSCI.19-11-04189.1999

Johansen, 1995, Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors, Mol Pharmacol, 48, 946

10.1038/325529a0

Johnson, 1996, Modulation of channel function by polyamines, Trends Pharmacol Sci, 17, 22, 10.1016/0165-6147(96)81566-5

10.1016/j.tins.2003.10.010

10.1124/jpet.106.105601

Jones, 2002, The NMDA receptor M3 segment is a conserved transduction element coupling ligand binding to channel opening, J Neurosci, 22, 2044, 10.1523/JNEUROSCI.22-06-02044.2002

Jones, 1990, Philanthotoxin blocks quisqualate-, AMPA- and kainate-, but not NMDA-, induced excitation of rat brainstem neurones in vivo, Br J Pharmacol, 101, 968, 10.1111/j.1476-5381.1990.tb14189.x

10.1111/j.1471-4159.2004.02985.x

10.1113/jphysiol.2005.095554

10.1038/nn1189

10.1113/jphysiol.2007.141291

10.1113/jphysiol.2006.127100

10.1523/JNEUROSCI.6013-08.2009

10.1126/science.8389056

10.1016/S1474-4422(08)70165-0

10.1113/jphysiol.1995.sp020812

10.1113/jphysiol.2003.058842

10.1016/S1044-7431(03)00214-8

10.1126/science.273.5280.1402

10.1038/nature04302

10.1038/emboj.2009.338

10.1038/sj.npp.1301504

10.1016/0092-8674(95)90334-8

Kashiwagi, 1996, An aspartate residue in the extracellular loop of the N-methyl-d-aspartate receptor controls sensitivity to spermine and protons, Mol Pharmacol, 49, 1131

10.1124/mol.61.3.533

10.1124/mol.52.4.701

10.1016/j.jmb.2006.01.024

10.1073/pnas.0611170104

10.1016/j.neuron.2008.07.034

10.1523/JNEUROSCI.5561-06.2007

10.1016/j.bmcl.2007.08.014

10.1074/jbc.M512728200

10.1073/pnas.85.17.6547

10.1038/nrn2501

10.1016/j.neuron.2009.01.015

10.1111/j.1471-4159.1989.tb01881.x

10.1001/jama.289.23.3095

10.1113/jphysiol.1996.sp021807

10.1038/sj.bjp.0701634

10.1038/23040

Kidd, 2001, Kinetics and activation of postsynaptic kainate receptors at thalamocortical synapses: role of glutamate clearance, J Neurophysiol, 86, 1139, 10.1152/jn.2001.86.3.1139

10.1016/j.neuron.2009.03.001

10.1124/jpet.104.082990

Kiskin, 1989, [Argiopine, argiopinines and pseudoargiopinines—blockers of the glutamate receptors in hippocampal neurons], Neirofiziologiia, 21, 748

10.4161/chan.1.6.5589

10.1021/bi000962i

10.1126/science.2841759

Kleckner, 1989, Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-d-aspartate receptors, Mol Pharmacol, 36, 430

10.1016/S0378-1119(98)00005-5

10.1074/jbc.M102428200

10.1523/JNEUROSCI.0660-04.2004

10.1124/mol.65.6.1386

10.1186/1756-6606-1-2

10.1038/73877

10.1007/s00441-006-0273-6

10.1016/0896-6273(94)90311-5

10.1113/jphysiol.1996.sp021320

10.1016/S0168-0102(97)00067-9

Koike, 2000, Regulation of kinetic properties of GluR2 AMPA receptor channels by alternative splicing, J Neurosci, 20, 2166, 10.1523/JNEUROSCI.20-06-02166.2000

10.1111/j.1460-9568.2005.04319.x

10.1074/jbc.M611182200

10.1126/science.7569905

10.1016/j.neuroscience.2007.02.012

10.1523/JNEUROSCI.3703-08.2009

10.1113/jphysiol.2009.176297

10.1016/j.neuroscience.2007.12.047

10.1523/JNEUROSCI.4185-06.2007

10.1016/0006-8993(94)90035-3

10.1074/jbc.273.40.26218

10.1016/S0022-510X(01)00626-8

10.1017/S0952523809990149

10.1021/jm020314s

Krupp, 1996, Calcium-dependent inactivation of recombinant N-methyl-d-aspartate receptors is NR2 subunit specific, Mol Pharmacol, 50, 1680

10.1016/S0896-6273(00)80459-6

10.1016/S0028-3908(02)00031-X

10.1001/archpsyc.59.7.663

Kumamoto, 1996, Neuromodulation by Mg2+ and polyamines of excitatory amino acid currents in rodent neurones in culture, Magnes Res, 9, 317

10.1038/nsmb.1613

Kumar, 2002, A developmental switch of AMPA receptor subunits in neocortical pyramidal neurons, J Neurosci, 22, 3005, 10.1523/JNEUROSCI.22-08-03005.2002

Kuner, 2001, Channel-lining residues of the AMPA receptor M2 segment: structural environment of the Q/R site and identification of the selectivity filter, J Neurosci, 21, 4162, 10.1523/JNEUROSCI.21-12-04162.2001

Kuner, 1996, Multiple structural elements determine subunit specificity of Mg2+ block in NMDA receptor channels, J Neurosci, 16, 3549, 10.1523/JNEUROSCI.16-11-03549.1996

10.1097/00001756-199312000-00029

10.1016/S0166-2236(02)00010-3

10.1016/S0896-6273(00)80165-8

10.1038/35039564

10.1073/pnas.0900892106

10.1016/0896-6273(94)90445-6

10.1016/j.biopsych.2006.12.020

10.1523/JNEUROSCI.0281-09.2009

10.1038/358036a0

10.1074/jbc.274.41.28937

10.1016/0304-3940(92)90870-D

10.1016/j.neuron.2008.10.045

10.1016/j.neubiorev.2009.08.002

10.1126/science.285.5432.1411

10.1016/S0304-3940(98)00293-6

10.1093/emboj/17.16.4704

10.1001/archpsyc.62.11.1196

10.1016/j.biopsych.2006.04.005

10.1016/j.biopsych.2007.04.038

Lang, 2002, Management of Parkinson's disease: An evidence-based review, Mov Disord, 17, S1, 10.1002/mds.10108

10.1124/jpet.107.129890

10.1016/j.str.2007.07.015

10.1074/jbc.270.34.20036

Laube, 1998, Evidence for a tetrameric structure of recombinant NMDA receptors, J Neurosci, 18, 2954, 10.1523/JNEUROSCI.18-08-02954.1998

10.1016/j.neuropharm.2004.07.041

Lauterborn, 2000, Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons, J Neurosci, 20, 8, 10.1523/JNEUROSCI.20-01-00008.2000

10.1523/JNEUROSCI.1890-04.2004

10.1016/j.tins.2003.09.007

10.2174/0929867043363901

10.2174/156802606776894447

10.1016/S0028-3908(01)00170-8

10.1113/jphysiol.2007.130377

10.1038/35016089

10.1016/S0092-8674(03)00122-3

10.1016/j.mcn.2007.06.003

10.1016/S0896-6273(02)01024-3

10.1016/S0140-6736(00)02326-6

Legendre, 1993, Inactivation of NMDA channels in cultured hippocampal neurons by intracellular calcium, J Neurosci, 13, 674, 10.1523/JNEUROSCI.13-02-00674.1993

10.1113/jphysiol.1990.sp018266

10.1016/S0896-6273(02)00608-6

Lei, 2001, Positive allosteric modulators of AMPA receptors reduce proton-induced receptor desensitization in rat hippocampal neurons, J Neurophysiol, 85, 2030, 10.1152/jn.2001.85.5.2030

10.1074/jbc.M205164200

10.1074/jbc.273.31.19518

10.1073/pnas.96.6.3239

LePage, 2005, Differential binding properties of [3H]dextrorphan and [3H]MK-801 in heterologously expressed NMDA receptors, Neuropharmacology, 49, 1, 10.1016/j.neuropharm.2005.01.029

10.1073/pnas.87.6.2354

10.1038/346565a0

Lester, 1993, Interactions between the glycine and glutamate binding sites of the NMDA receptor, J Neurosci, 13, 1088, 10.1523/JNEUROSCI.13-03-01088.1993

10.1038/1228

Leung HW Wong PT Low CM (2007) Regulation of NR1/NR2B NMDA receptor function by thrombin. Soc Neuosci Abstr 33:678.16/F28.

10.1074/jbc.274.24.16907

10.1096/fj.08-107268

10.1073/pnas.211428098

10.1038/375400a0

10.1523/JNEUROSCI.1750-07.2007

10.1038/nn.2351

10.1074/jbc.270.24.14255

10.1016/S0028-3908(01)00013-2

10.1016/S0166-2236(02)02245-2

10.1016/j.tins.2008.02.005

10.1074/jbc.M311267200

10.1074/jbc.M105399200

10.1074/jbc.M211165200

10.1016/S0006-8993(97)01567-9

10.1126/science.1096615

10.1038/35013064

10.1038/nrn1106

10.1161/01.STR.0000153069.96296.fd

10.1016/j.neuropharm.2008.08.006

10.1126/science.7992055

10.1046/j.1460-9568.1999.00432.x

10.1038/nn0702-614

10.1126/science.2467382

Lovinger, 1990, NMDA receptor-mediated synaptic excitation selectively inhibited by ethanol in hippocampal slice from adult rat, J Neurosci, 10, 1372, 10.1523/JNEUROSCI.10-04-01372.1990

10.1124/mol.63.6.1212

10.1073/pnas.180307497

10.1152/jn.00078.2006

10.1016/S0896-6273(01)00501-3

10.1016/j.neuron.2009.02.027

10.1523/JNEUROSCI.1786-08.2008

10.1001/archneurpsyc.1959.02340150095011

10.1021/jm021020+

10.1124/mol.51.1.79

10.1186/1471-2202-5-44

10.1006/bbrc.2002.6413

Lynch, 1996, Inhibition of N-methyl-d-aspartate receptors by haloperidol: developmental and pharmacological characterization in native and recombinant receptors, J Pharmacol Exp Ther, 279, 154

10.1038/nn935

10.1016/j.coph.2005.09.005

10.1016/j.tins.2006.07.007

10.1006/exnr.1997.6447

10.1038/321519a0

10.1126/science.1059365

10.1016/S0014-5793(03)01104-9

Madden, 2002, The inner workings of the AMPA receptors, Curr Opin Drug Discov Devel, 5, 741

10.1074/jbc.M414523200

10.1021/bi048447y

10.1111/j.1469-7793.1997.655ba.x

10.1523/JNEUROSCI.4573-04.2005

10.1016/S0304-3959(02)00456-6

10.1038/sj.bjp.0704543

10.1038/nn877

10.1016/j.neuron.2004.09.012

10.1146/annurev.neuro.25.112701.142758

10.1126/science.1142365

10.1074/jbc.272.51.32528

10.1073/pnas.0611698104

10.1097/00001756-199801260-00027

10.1016/S0896-6273(01)00520-7

10.1016/S0165-0173(99)00020-X

10.1007/BF03033978

10.1016/S0920-9964(01)00311-5

10.1016/0306-4522(93)90199-P

10.1038/nature05736

Masood, 1994, Differential ethanol sensitivity of recombinant N-methyl-d-aspartate receptor subunits, Mol Pharmacol, 45, 324

10.1523/JNEUROSCI.1697-04.2004

10.1124/mol.55.6.957

Masuko, 1999, Stimulatory and inhibitory properties of aminoglycoside antibiotics at N-methyl-d-aspartate receptors, J Pharmacol Exp Ther, 290, 1026

10.1017/S1461145709000169

Matsuda, 2003, Specific assembly with the NMDA receptor 3B subunit controls surface expression and calcium permeability of NMDA receptors, J Neurosci, 23, 10064, 10.1523/JNEUROSCI.23-31-10064.2003

10.1016/S0169-328X(02)00173-0

10.1074/jbc.M410513200

10.1126/science.1185152

10.1046/j.1471-4159.1999.731765.x

Mayat, 1995, Immunoprecipitation, immunoblotting, and immunocytochemistry studies suggest that glutamate receptor delta subunits form novel postsynaptic receptor complexes, J Neurosci, 15, 2533, 10.1523/JNEUROSCI.15-03-02533.1995

10.1016/j.neuron.2005.01.031

10.1038/nature04709

10.1523/JNEUROSCI.0123-06.2005

10.1038/338425a0

10.1113/jphysiol.1987.sp016883

10.1038/309261a0

Mayer, 1988, Sites of antagonist action on N-methyl-D-aspartic acid receptors studied using fluctuation analysis and a rapid perfusion technique, J Neurophysiol, 60, 645, 10.1152/jn.1988.60.2.645

McBain, 1989, Structural requirements for activation of the glycine coagonist site of N-methyl-d-aspartate receptors expressed in Xenopus oocytes, Mol Pharmacol, 36, 556

10.1213/01.ANE.0000108501.57073.38

10.1517/13543776.15.4.389

10.1021/jm030483s

10.1038/nm0398-291

10.1021/bi026010p

10.1096/fj.03-0873rev

10.1016/0304-3940(90)90157-5

Mealing, 1999, Differences in degree of trapping of low-affinity uncompetitive N-methyl-D-aspartic acid receptor antagonists with similar kinetics of block, J Pharmacol Exp Ther, 288, 204

Mealing, 2001, Structural modifications to an N-methyl-d-aspartate receptor antagonist result in large differences in trapping block, J Pharmacol Exp Ther, 297, 906

10.1074/jbc.M101382200

10.1113/jphysiol.1995.sp020540

10.1016/S0028-3908(02)00336-2

10.1016/S0896-6273(02)00624-4

10.1021/bi051084x

10.1002/prot.1111

10.1016/S0896-6273(03)00368-4

10.1161/01.STR.0000048216.90221.9C

Menniti, 2000, Characterization of the binding site for a novel class of noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonists, Mol Pharmacol, 58, 1310, 10.1124/mol.58.6.1310

10.1126/science.1146317

10.1074/jbc.M106744200

10.1001/jama.285.5.535

10.1038/nature04474

10.1016/j.jmb.2008.07.021

10.1159/000096408

10.1038/355722a0

10.1073/pnas.0905570106

10.1016/j.neuron.2007.08.022

10.1016/0028-3908(94)00155-L

10.1192/bjp.bp.105.011692

10.1016/S0028-3908(01)00027-2

10.1002/cne.21822

Miyagi, 2002, Delphilin: a novel PDZ and formin homology domain-containing protein that synaptically colocalizes and interacts with glutamate receptor delta 2 subunit, J Neurosci, 22, 803, 10.1523/JNEUROSCI.22-03-00803.2002

10.1038/nature01748

10.1017/S1041610203009219

10.1016/0006-8993(82)90981-7

10.1111/j.1476-5381.2009.00304.x

10.1016/0896-6273(94)90210-0

10.1126/science.256.5060.1217

10.1038/35102000

10.1016/j.neuropharm.2004.03.005

10.1042/BSR20080058

10.1038/358673a0

10.1016/j.neuron.2008.11.009

10.1016/j.biopsych.2006.07.025

10.1038/354031a0

10.1021/jm0492498

10.1126/science.7973663

10.1016/j.bmc.2009.05.085

Mosley CA Acker TM Hansen KB Mullasseril P Andersen K Le P Vellano KM Bräuner-Osborne H Liotta DC Traynelis SF (2010) Quinazolin-4-one derivatives: A novel class of non-competitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists. J Med Chem, DOI: 10.1021/jm100027p .

10.1073/pnas.97.9.4926

10.1523/JNEUROSCI.3567-07.2008

10.1038/3661

Mott, 2003, Subunit-dependent modulation of kainate receptors by extracellular protons and polyamines, J Neurosci, 23, 1179, 10.1523/JNEUROSCI.23-04-01179.2003

10.1016/S0896-6273(03)00676-7

10.1016/S0896-6273(00)80157-9

10.1016/j.coph.2005.12.002

Muir KW Lees KR (2003) Excitatory amino acid antagonists for acute stroke. Cochrane Database Syst Rev:CD001244.

10.1016/S0896-6273(00)00126-4

10.1074/mcp.M600046-MCP200

10.1124/jpet.103.049445

10.1017/S1740925X05000141

10.1073/pnas.0813105106

10.1146/annurev.pharmtox.39.1.221

10.1523/JNEUROSCI.4127-03.2004

Myers, 1998, Transcriptional regulation of the GluR2 gene: neural-specific expression, multiple promoters, and regulatory elements, J Neurosci, 18, 6723, 10.1523/JNEUROSCI.18-17-06723.1998

Nagasawa, 1996, Gene structure and chromosomal localization of the mouse NMDA receptor channel subunits, Mol Brain Res, 36, 1, 10.1016/0169-328X(95)00225-H

10.2174/157015908783769662

10.1016/S0006-3495(01)76188-7

10.2302/kjm.57.105

10.1038/nature03328

10.1515/BC.2006.024

10.1016/0896-6273(90)90212-X

10.1073/pnas.89.18.8552

10.1523/JNEUROSCI.1067-09.2009

10.1074/jbc.M008085200

10.1073/pnas.0409573102

10.1038/sj.emboj.7601911

10.1073/pnas.0703718104

10.1016/j.febslet.2005.01.012

10.1124/mol.109.056598

Nedergaard, 1991, Dynamics of interstitial and intracellular pH in evolving brain infarct, Am J Physiol, 260, R581

Neely, 1986, Trapping of an open-channel blocker at the frog neuromuscular acetylcholine channel, Biophys J, 50, 981, 10.1016/S0006-3495(86)83538-X

10.1016/0028-3908(95)00144-U

10.1523/JNEUROSCI.5242-05.2006

10.1371/journal.pbio.1000041

10.1111/j.1471-4159.1989.tb09126.x

10.1124/mol.63.1.19

Niethammer, 1996, Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases, J Neurosci, 16, 2157, 10.1523/JNEUROSCI.16-07-02157.1996

10.1111/j.1471-4159.2005.02977.x

10.2174/1381612024607072

10.1097/00000539-200010000-00036

10.1021/ja0705801

Nishi, 2001, Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner, J Neurosci, 21, RC185, 10.1523/JNEUROSCI.21-23-j0003.2001

10.1113/jphysiol.1994.sp020051

10.1016/S0896-6273(00)80517-6

10.1016/j.biopsych.2008.01.012

10.1038/307462a0

10.1111/j.1471-4159.2005.03410.x

10.1002/mds.22169

10.1016/S0896-6273(00)80782-5

10.1038/nn1476

10.1016/0896-6273(93)90269-W

10.1016/S0169-328X(02)00440-0

10.1016/S0169-328X(99)00250-8

10.1016/S0022-3956(99)00029-1

10.1016/0361-9230(87)90077-3

10.1074/jbc.271.49.31670

O'Neill, 2007, AMPA receptor potentiators as cognitive enhancers, IDrugs, 10, 185

10.2174/138945007780618517

10.1016/S0028-3908(98)00134-8

10.1016/S0896-6273(00)80518-8

10.2174/138945007780618526

10.1016/j.ejphar.2009.04.034

10.1002/syn.20009

10.1038/37795

10.1016/S0166-2236(97)01184-3

10.1016/S0896-6273(00)80228-7

10.1016/S0304-3940(97)00176-6

10.1523/JNEUROSCI.0170-04.2004

10.1016/j.cell.2006.02.051

10.1085/jgp.117.4.345

10.1111/j.1469-7793.1999.t01-1-00337.x

10.1016/0896-6273(94)90032-9

Paoletti, 1997, High-affinity zinc inhibition of NMDA NR1-NR2A receptors, J Neurosci, 17, 5711, 10.1523/JNEUROSCI.17-15-05711.1997

10.1016/S0896-6273(00)00163-X

10.1016/j.neuroscience.2008.01.061

10.1074/jbc.M313446200

10.1177/1073858407305833

10.1523/JNEUROSCI.4514-08.2009

10.1016/j.neuron.2005.11.035

10.1124/mol.52.6.1113

10.1523/JNEUROSCI.4280-08.2009

10.1016/0028-3908(95)00092-K

Parsons CG Danysz W Lodge D (2002) Introduction to glutamate receptors, their function and pharmacology, in Ionotropic Glutamate Receptors as Therapeutic Targets ( Danysz W Lodge D Parsons CG eds) pp 1–30, F. P. Graham Publishing Co., Johnson City, TN.

10.1016/S0028-3908(99)00019-2

10.1016/0896-6273(95)90227-9

Partin, 1996, AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate, J Neurosci, 16, 6634, 10.1523/JNEUROSCI.16-21-06634.1996

Partin, 1994, Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants, Mol Pharmacol, 46, 129

10.1016/0896-6273(93)90220-L

10.1074/jbc.M208349200

Paternain, 2003, A role for extracellular Na+ in the channel gating of native and recombinant kainate receptors, J Neurosci, 23, 8641, 10.1523/JNEUROSCI.23-25-08641.2003

Patneau, 1993, Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate, J Neurosci, 13, 3496, 10.1523/JNEUROSCI.13-08-03496.1993

10.1196/annals.1300.016

10.1021/bi062213s

10.1021/bi8015907

Pelkey KA McBain CJ (2008) Ionotropic glutamate receptors in synaptic plasticity, in The Glutamate Receptors ( Gereau RW Swanson GT eds) pp 179–246, Humana Press, Totowa, NJ.

10.1038/emboj.2008.222

10.1016/j.bcp.2003.08.013

10.1039/b515111b

10.1097/00001756-199901180-00019

10.1016/0006-8993(85)91612-9

10.1038/nn1680

Perez-Otano, 2001, Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors, J Neurosci, 21, 1228, 10.1523/JNEUROSCI.21-04-01228.2001

Perin-Dureau, 2002, Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors, J Neurosci, 22, 5955, 10.1523/JNEUROSCI.22-14-05955.2002

10.1016/j.neuropharm.2008.08.002

10.1126/science.2883728

10.1016/j.mcn.2005.03.013

Petralia, 1994, The NMDA receptor subunits NR2A and NR2B show histological and ultrastructural localization patterns similar to those of NR1, J Neurosci, 14, 6102, 10.1523/JNEUROSCI.14-10-06102.1994

10.1002/cne.903180309

Petralia RS Wenthold RJ (2008) NMDA receptors, in The Glutamate Receptors ( Gereau RW Swanson GT eds) pp 45–98, Humana Press, Totowa, NJ.

10.1213/01.ANE.0000081061.12235.55

10.1523/JNEUROSCI.1407-05.2005

10.1073/pnas.0800643105

Pickard, 2000, Developmental changes in synaptic AMPA and NMDA receptor distribution and AMPA receptor subunit composition in living hippocampal neurons, J Neurosci, 20, 7922, 10.1523/JNEUROSCI.20-21-07922.2000

10.1046/j.1460-9568.1999.00629.x

10.1113/jphysiol.2001.014001

10.1038/nn1678

10.1016/j.neuron.2008.04.001

10.1016/j.neuron.2007.02.025

10.1016/j.neuropharm.2008.07.013

10.1038/nn1044

10.1038/nature02775

10.1016/S0896-6273(00)80107-5

10.1085/jgp.109.2.181

10.1016/j.neulet.2006.03.051

10.1097/JCP.0b013e31818a6cea

10.1523/JNEUROSCI.4834-04.2005

10.1016/j.neuron.2006.12.006

Priestley, 1994, Kinetic study of the interactions between the glutamate and glycine recognition sites on the N-methyl-D-aspartic acid receptor complex, Mol Pharmacol, 46, 1191

Priestley, 1995, Pharmacological properties of recombinant human N-methyl-d-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells, Mol Pharmacol, 48, 841

10.1523/JNEUROSCI.5613-09.2010

10.2174/138945007780618481

10.1016/j.neuron.2005.08.016

10.1111/j.1471-4159.1987.tb10024.x

10.1113/jphysiol.2001.012685

10.1016/S0031-9384(02)00906-X

10.1523/JNEUROSCI.3453-06.2006

10.1124/mol.104.010751

10.1111/j.1471-4159.2005.03464.x

10.1074/jbc.M413915200

10.1074/jbc.M109.004960

10.1016/j.neuron.2008.09.040

10.1038/7263

10.1523/JNEUROSCI.2464-04.2004

10.1007/BF02260076

10.1523/JNEUROSCI.3967-04.2005

10.1016/j.neurobiolaging.2003.07.002

10.1124/mol.104.007872

10.1016/0922-4106(91)90052-J

10.1002/syn.890050406

10.1016/0896-6273(90)90199-P

10.1016/j.neuint.2004.10.004

10.1016/S0896-6273(01)00539-6

10.1056/NEJMoa013128

10.1074/jbc.M209486200

10.1001/archpsyc.61.11.1136

10.1038/nature03205

10.1016/S0378-1119(02)00833-8

Rieff, 1999, Neuregulin induces GABAA receptor subunit expression and neurite outgrowth in cerebellar granule cells, J Neurosci, 19, 10757, 10.1523/JNEUROSCI.19-24-10757.1999

10.1038/sj.emboj.7601865

10.1523/JNEUROSCI.0188-05.2005

Robert, 2003, How AMPA receptor desensitization depends on receptor occupancy, J Neurosci, 23, 847, 10.1523/JNEUROSCI.23-03-00847.2003

Robert, 2001, Subunit interactions and AMPA receptor desensitization, J Neurosci, 21, 5574, 10.1523/JNEUROSCI.21-15-05574.2001

10.1016/j.neuron.2009.06.016

10.1161/01.STR.0000209330.73175.34

Roche, 1999, Postsynaptic density-93 interacts with the delta2 glutamate receptor subunit at parallel fiber synapses, J Neurosci, 19, 3926, 10.1523/JNEUROSCI.19-10-03926.1999

10.1016/S0896-6273(00)80144-0

10.1016/S0896-6273(00)80501-2

10.1177/1049909108330025

10.1046/j.1471-4159.2001.00565.x

10.1126/science.280.5369.1596

10.1016/0896-6273(93)90197-Y

10.1016/0092-8674(95)90016-0

10.1038/44151

10.1111/j.1469-7793.1998.361bh.x

10.1523/JNEUROSCI.4041-05.2005

Rumbaugh, 1999, Distinct synaptic and extrasynaptic NMDA receptors in developing cerebellar granule neurons, J Neurosci, 19, 10603, 10.1523/JNEUROSCI.19-24-10603.1999

10.1001/jama.285.13.1719

10.1523/JNEUROSCI.5807-08.2009

10.1021/bi011143g

10.1074/jbc.M109.039891

10.1016/j.neuron.2007.04.012

10.1021/jm800092x

10.1021/ja963953z

10.1021/ol015798l

Sakai, 2001, Pharmacological properties of the potent epileptogenic amino acid dysiherbaine, a novel glutamate receptor agonist isolated from the marine sponge Dysidea herbacea, J Pharmacol Exp Ther, 296, 650

10.1074/jbc.M608194200

Salopek-Sondi, 2003, (19)F NMR studies of the leucine-isoleucine-valine binding protein: evidence that a closed conformation exists in solution, J Biomol Struct Dyn, 21, 235, 10.1080/07391102.2003.10506919

10.1038/nature04301

10.1111/j.1471-4159.2008.05687.x

10.1016/j.neuint.2005.04.011

10.1124/jpet.105.086389

10.1097/00000542-200205000-00005

10.1111/j.1468-2982.2004.00723.x

Sang, 2003, The NR2B subunit-selective NMDA receptor antagonist CP-101,606 reduces pain intensity in patients with central and peripheral neuropathic pain, Soc Neurosci Abstr, 29, 814.9

10.1038/ncb990

Sans, 2001, Synapse-associated protein 97 selectively associates with a subset of AMPA receptors early in their biosynthetic pathway, J Neurosci, 21, 7506, 10.1523/JNEUROSCI.21-19-07506.2001

10.1152/jn.00531.2001

10.1074/jbc.271.35.21316

10.1126/science.284.5421.1845

10.1161/STROKEAHA.109.552554

10.1161/01.STR.0000124458.98123.52

10.1038/72915

10.1073/pnas.94.5.2013

10.1016/S0896-6273(00)80404-3

10.1038/sj.bjp.0706233

10.1523/JNEUROSCI.3175-07.2007

10.1016/j.jmb.2007.11.105

10.1016/j.mcn.2009.06.004

10.1016/j.jmb.2009.05.008

10.1124/mol.105.016840

10.1007/s00213-004-2110-5

10.1016/S0006-3495(96)79782-5

10.1016/S0006-3495(98)77889-0

10.1016/S0896-6273(01)80055-6

10.1073/pnas.172511199

10.1016/0014-2999(91)90719-7

Schorge, 2003, Studies of NMDA receptor function and stoichiometry with truncated and tandem subunits, J Neurosci, 23, 1151, 10.1523/JNEUROSCI.23-04-01151.2003

10.1113/jphysiol.2005.095349

10.1523/JNEUROSCI.1739-04.2004

10.1074/jbc.M703539200

10.1523/JNEUROSCI.2100-04.2004

10.1126/science.1167852

10.1016/S0028-3908(03)00250-8

Scott, 2001, An NMDA receptor ER retention signal regulated by phosphorylation and alternative splicing, J Neurosci, 21, 3063, 10.1523/JNEUROSCI.21-09-03063.2001

Sedlácek, 2008, Neurosteroid modulation of ionotropic glutamate receptors and excitatory synaptic transmission, Physiol Res, 57, S49, 10.33549/physiolres.931600

Seidenman, 2003, Glutamate receptor subunit 2 Serine 880 phosphorylation modulates synaptic transmission and mediates plasticity in CA1 pyramidal cells, J Neurosci, 23, 9220, 10.1523/JNEUROSCI.23-27-09220.2003

Sekiguchi, 1997, A novel allosteric potentiator of AMPA receptors: 4–2-(phenylsulfonylamino)ethylthio-2,6-difluoro-phenoxyacetamide, J Neurosci, 17, 5760, 10.1523/JNEUROSCI.17-15-05760.1997

10.1038/sj.bjp.0704804

10.1038/sj.bjp.0701707

10.1016/j.neuron.2009.07.017

10.1038/89506

10.1073/pnas.96.5.2414

10.1016/j.neuron.2007.09.016

10.1016/j.mcn.2005.01.006

10.1073/pnas.93.24.14170

10.1126/science.2154034

10.1016/S0028-3908(01)00073-9

Shen, 2000, Regulation of AMPA receptor GluR1 subunit surface expression by a 4. 1N-linked actin cytoskeletal association, J Neurosci, 20, 7932, 10.1523/JNEUROSCI.20-21-07932.2000

10.1016/S0304-3940(98)00938-0

10.1038/368144a0

10.1016/j.neuropharm.2007.04.016

10.1146/annurev.cellbio.23.090506.123516

10.1016/S0092-8674(01)00321-X

10.1016/j.neuron.2009.05.016

10.1007/s00406-007-0757-8

10.1152/jn.01054.2004

10.1016/0006-8993(89)90207-2

10.1111/j.1460-9568.2005.04079.x

10.1016/j.neulet.2005.08.063

Shoulson, 2001, A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease, Neurology, 56, 455, 10.1212/WNL.56.4.455

10.1016/j.neuron.2007.06.020

10.1016/S0079-6123(08)61980-9

10.1073/pnas.0811228106

10.1016/S0028-3908(97)00188-3

Simpkins, 2003, Selective activation induced cleavage of the NR2B subunit by calpain, J Neurosci, 23, 11322, 10.1523/JNEUROSCI.23-36-11322.2003

10.1097/AJP.0b013e31802f67a7

10.1111/j.1527-3458.2007.00006.x

10.1002/cmdc.200800226

10.1038/nn1664

10.1016/j.tips.2009.09.002

Smith, 1992, Effects of acromelic acid A on the binding of [3H]-kainic acid and [3H]-AMPA to rat brain synaptic plasma membranes, Br J Pharmacol, 105, 83, 10.1111/j.1476-5381.1992.tb14214.x

10.1016/S0028-3908(98)00122-1

Small DL Tauskela JS (2005) Glutamate receptor pharmacology: lessons learned from the last decade of stroke trials, in Glutamate Receptors in Peripheral Tissue: Excitatory Transmission Outside the CNS ( Gill S Pulido O eds) pp 27–45, Kluwer Academic/Plenum Publishers, New York.

10.1124/jpet.108.147884

10.1038/79931

10.1124/jpet.107.123836

10.1038/nn1503

10.1016/j.neuron.2006.11.016

10.1016/S0006-3495(98)77844-0

10.1016/S0896-6273(01)00560-8

10.1111/j.1469-7793.1998.047bf.x

Sobolevsky, 1999, Probing of NMDA channels with fast blockers, J Neurosci, 19, 10611, 10.1523/JNEUROSCI.19-24-10611.1999

10.1085/jgp.200609718

10.1016/S0006-3495(02)75331-9

10.1038/nature08624

Sobolevsky, 2003, Different gating mechanisms in glutamate receptor and K+ channels, J Neurosci, 23, 7559, 10.1523/JNEUROSCI.23-20-07559.2003

10.1016/S0896-6273(04)00008-X

Sommer, 1992, A glutamate receptor channel with high affinity for domoate and kainate, EMBO J, 11, 1651, 10.1002/j.1460-2075.1992.tb05211.x

10.1126/science.1699275

10.1016/0092-8674(91)90568-J

10.1016/S0166-2236(02)02270-1

10.1016/S0896-6273(00)80548-6

10.1016/S0960-894X(96)00284-3

10.1038/nn1966

10.1038/nn.2266

Spivak V Lin A Beebe P Stoll L Gentile L (2004) Identification of a neurosteroid binding site contained within the GluR2–S1S2 domain, in 95th American Oil Chemists Society Annual Meeting, pp 811–819; Cincinnati, OH; 2004 May 9–12. American Oil Chemists Society, Urbana, IL.

10.1016/S0896-6273(00)80568-1

10.1016/S0896-6273(00)80310-4

10.1007/PL00000635

Standley, 1998, High- and low-affinity alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid ([3H]AMPA) binding sites represent immature and mature forms of AMPA receptors and are composed of differentially glycosylated subunits, J Neurochem, 70, 2434, 10.1046/j.1471-4159.1998.70062434.x

10.1016/j.mcn.2008.02.003

10.1073/pnas.91.23.11158

Stein, 1992, Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes, Mol Pharmacol, 42, 864

10.1016/j.neuron.2006.02.025

10.1016/S0014-2999(99)00512-9

10.1016/S0014-2999(00)00916-X

10.1098/rspb.1992.0159

Stern, 1994, Single channel properties of cloned NMDA receptors in a human cell line: comparison with results from Xenopus oocytes, J Physiol, 476, 391, 10.1113/jphysiol.1994.sp020140

10.1016/0896-6273(94)90420-0

10.1016/S0896-6273(00)80605-4

Steward, 1982, Preferential localization of polyribosomes under the base of dendritic spines in granule cells of the dentate gyrus, J Neurosci, 2, 284, 10.1523/JNEUROSCI.02-03-00284.1982

Steward, 1988, Protein-synthetic machinery beneath postsynaptic sites on CNS neurons: association between polyribosomes and other organelles at the synaptic site, J Neurosci, 8, 176, 10.1523/JNEUROSCI.08-01-00176.1988

10.1146/annurev.neuro.24.1.299

10.1529/biophysj.106.089896

10.1074/jbc.273.33.20689

10.2174/138620706775541918

10.1016/S0028-3908(03)00275-2

10.1016/j.tips.2007.10.003

10.1074/jbc.270.1.41

Suchanek, 1997, Tissue specific control regions of the N-methyl-d-aspartate receptor subunit NR2C promoter, Biol Chem, 378, 929

Sucher, 1995, Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDARL) in the rodent brain, J Neurosci, 15, 6509, 10.1523/JNEUROSCI.15-10-06509.1995

Sucher, 1993, Expression of endogenous NMDAR1 transcripts without receptor protein suggests post-transcriptional control in PC12 cells, J Biol Chem, 268, 22299, 10.1016/S0021-9258(18)41528-1

10.1002/jnr.490300316

10.1016/j.pbb.2006.04.018

10.1016/0896-6273(94)90258-5

10.1038/417245a

10.1006/exnr.1997.6691

10.2174/138945007780618535

10.1016/j.cell.2006.03.040

10.1523/JNEUROSCI.2191-05.2005

10.1038/npp.2008.158

Swanson, 1996, Effect of RNA editing and subunit co-assembly single-channel properties of recombinant kainate receptors, J Physiol, 492, 129, 10.1113/jphysiol.1996.sp021295

10.1016/S0896-6273(00)80972-1

Swanson, 1998, Kainate receptors exhibit differential sensitivities to (S)-5-iodowillardiine, Mol Pharmacol, 53, 942

10.1016/S0896-6273(02)00676-1

10.1111/j.1469-7793.1998.639ba.x

Swanson, 1997, Single-channel properties of recombinant AMPA receptors depend on RNA editing, splice variation, and subunit composition, J Neurosci, 17, 58, 10.1523/JNEUROSCI.17-01-00058.1997

10.1038/nrn1559

10.1016/0169-328X(96)00100-3

10.1096/fj.07-101402

10.1016/j.bmc.2009.07.021

10.1016/S0304-3940(97)00792-1

10.1021/jm8002153

10.1074/jbc.M805055200

10.1016/j.neuron.2006.11.023

10.1111/j.1527-3458.2002.tb00232.x

10.1126/science.1065983

10.1021/jm990199u

10.1021/jm980235+

10.1038/sj.gt.3302376

10.1073/pnas.261713299

10.1073/pnas.87.16.6445

10.1098/rstb.2001.0887

10.1038/43432

10.1016/S0028-3908(01)00122-8

10.1038/sj.bjp.0701445

10.4088/JCP.v67n0103

10.1074/jbc.M706611200

10.1073/pnas.1133424100

10.1002/syn.890130111

10.1152/jn.00771.2005

10.1038/sj.emboj.7601969

10.1016/j.jmb.2004.09.048

Tikhonov, 2002, Modeling of the pore domain of the GLUR1 channel: homology with K+ channel and binding of channel blockers, Biophys J, 82, 1884, 10.1016/S0006-3495(02)75538-0

10.1016/j.neuropharm.2007.11.014

10.1007/s12031-008-9172-5

10.1074/jbc.272.8.5157

10.1038/nature03624

10.1083/jcb.200212116

10.1126/science.1090262

10.1016/j.neuropharm.2006.07.012

10.1016/j.neuron.2005.01.009

10.1111/j.1460-9568.2009.06841.x

10.1111/j.1469-7793.2000.00041.x

10.1016/j.neuropharm.2007.05.005

Traynelis, 1998, Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit, J Neurosci, 18, 6163, 10.1523/JNEUROSCI.18-16-06163.1998

10.1038/345347a0

10.1113/jphysiol.1991.sp018453

10.1126/science.7754371

10.1111/j.1469-7793.1997.513bg.x

10.1074/mcp.M700170-MCP200

10.1176/appi.ajp.163.1.28

10.1146/annurev.pharmtox.42.082701.160735

10.1016/j.biopsych.2003.09.012

10.1016/j.biopsych.2005.06.032

10.1074/jbc.M600966200

Tsuzuki, 1994, Ion permeation properties of the cloned mouse epsilon 2/zeta 1 NMDA receptor channel, Mol Brain Res, 26, 37, 10.1016/0169-328X(94)90071-X

10.1016/j.cell.2009.12.055

10.1016/j.schres.2004.05.005

10.1523/JNEUROSCI.1108-05.2005

10.1073/pnas.95.18.10960

10.1021/bi802259a

10.1016/0014-5793(95)00315-Z

10.1111/j.1471-4159.2006.03831.x

10.1016/j.bbrc.2008.10.170

10.1016/j.mcn.2004.02.007

10.1016/j.cell.2010.04.035

10.1038/nmeth1024

10.1073/pnas.0802075105

10.1006/exnr.2002.7876

10.1021/bi047984f

10.1021/jm030638w

10.1021/jm030428j

Vallano, 1996, Neuronal activity differentially regulates NMDA receptor subunit expression in cerebellar granule cells, J Neurosci, 16, 631, 10.1523/JNEUROSCI.16-02-00631.1996

10.1074/jbc.M411549200

10.1016/j.tins.2004.05.010

10.1073/pnas.0408269102

10.1159/000077526

10.1152/jn.01038.2002

10.1523/JNEUROSCI.1380-04.2004

Varney, 1996, Stable expression and characterization of recombinant human heteromeric N-methyl-d-aspartate receptor subtypes NMDAR1A/2A and NMDAR1A/2B in mammalian cells, J Pharmacol Exp Ther, 279, 367

Varney, 1998, Pharmacological characterization of the human ionotropic glutamate receptor subtype GluR3 stably expressed in mammalian cells, J Pharmacol Exp Ther, 285, 358

10.1046/j.1365-2826.2002.00853.x

10.1126/science.1710829

10.1016/0922-4106(94)90024-8

Vicini, 1998, Functional and pharmacological differences between recombinant N-methyl-d-aspartate receptors, J Neurophysiol, 79, 555, 10.1152/jn.1998.79.2.555

10.1016/S0006-3495(95)80263-8

10.1016/S0896-6273(00)80460-2

10.1038/88404

10.1124/mol.61.3.595

10.1016/j.biopha.2006.06.021

10.1074/jbc.M512098200

10.1021/jm061439q

10.1002/1520-636X(2000)12:10<705::AID-CHIR2>3.0.CO;2-9

10.1016/S0896-6273(00)81149-6

10.1016/j.neulet.2006.12.041

10.1016/0896-6273(93)90113-6

10.1113/jphysiol.1993.sp019876

Vyklický, 1990, The effect of external pH changes on responses to excitatory amino acids in mouse hippocampal neurones, J Physiol, 430, 497, 10.1113/jphysiol.1990.sp018304

10.1523/JNEUROSCI.2552-06.2006

Wafford, 1995, Identification of amino acids in the N-methyl-d-aspartate receptor NR1 subunit that contribute to the glycine binding site, Mol Pharmacol, 47, 374

10.1124/mol.53.3.590

10.1073/pnas.0604482103

10.1073/pnas.0604520103

10.1159/000087929

10.2174/1568007053544183

10.1523/JNEUROSCI.3799-05.2006

10.1016/S0896-6273(04)00139-4

10.1038/nn1119

10.1111/j.1471-4159.2006.04208.x

10.1016/j.neulet.2006.11.006

Wang, 2003, Spatiotemporal relationships among D-serine, serine racemase, and D-amino acid oxidase during mouse postnatal development, Acta Pharmacol Sin, 24, 965

10.1016/j.neuron.2008.07.023

10.1111/j.1471-4159.2004.02845.x

Washburn, 1996, Block of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by polyamines and polyamine toxins, J Pharmacol Exp Ther, 278, 669

Washburn, 1997, Differential dependence on GluR2 expression of three characteristic features of AMPA receptors, J Neurosci, 17, 9393, 10.1523/JNEUROSCI.17-24-09393.1997

Watanabe, 2002, DRPEER: A motif in the extracellular vestibule conferring high Ca2+ flux rates in NMDA receptor channels, J Neurosci, 22, 10209, 10.1523/JNEUROSCI.22-23-10209.2002

10.1097/00001756-199212000-00027

10.1002/cne.903380305

10.1002/cne.903430403

10.1002/cne.903450212

10.1002/cne.903430402

Watanabe, 1999, NMDA receptor type 2D gene as target for estrogen receptor in the brain, Mol Brain Res, 63, 375, 10.1016/S0169-328X(98)00304-0

Weaver, 2000, Geometry and charge determine pharmacological effects of steroids on N-methyl-d-aspartate receptor-induced Ca2+ accumulation and cell death, J Pharmacol Exp Ther, 293, 747

10.1038/83993

10.1002/cncr.11330

Weinbroum, 2004, Dextromethorphan-associated epidural patient-controlled analgesia provides better pain- and analgesics-sparing effects than dextromethorphan-associated intravenous patient-controlled analgesia after bone-malignancy resection: a randomized, placebo-controlled, double-blinded study, Anesth Analg, 98, 714, 10.1213/01.ANE.0000100151.56901.EB

Weinbroum, 2002, Dextromethorphan for the reduction of immediate and late postoperative pain and morphine consumption in orthopedic oncology patients: a randomized, placebo-controlled, double-blind study, Cancer, 95, 1164, 10.1002/cncr.10784

Weinbroum, 2001, Dextromethorphan attenuation of postoperative pain and primary and secondary thermal hyperalgesia, Can J Anaesth, 48, 167, 10.1007/BF03019730

10.1007/BF03018952

10.1124/jpet.106.101428

10.1016/S0166-2236(00)01610-6

10.1016/j.neuropharm.2008.07.015

Wells, 2001, A role for the cytoplasmic polyadenylation element in NMDA receptor-A role for the cytoplasmic polyadenylation element in NMDA receptor-regulated mRNA translation in neurons, J Neurosci, 21, 9541, 10.1523/JNEUROSCI.21-24-09541.2001

10.1074/jbc.M006668200

10.1146/annurev.pharmtox.43.100901.135803

10.3357/ASEM.2055.2007

10.1038/328640a0

Westbrook, 1986, High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors in mouse spinal-cord neurons in cell culture, J Neurosci, 6, 3385, 10.1523/JNEUROSCI.06-11-03385.1986

10.1523/JNEUROSCI.1519-06.2006

10.1038/nsmb1178

10.1038/sj.npp.1301257

White, 2000, In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus, J Pharmacol Exp Ther, 292, 425

10.1126/science.1128134

Wiesenfeld-Hallin, 1998, Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?, Drugs, 55, 1, 10.2165/00003495-199855010-00001

10.1111/j.1469-7793.1998.331bb.x

10.1085/jgp.200810009

Wilding, 1996, Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors, Mol Pharmacol, 49, 540

Wilding, 1997, Activation and desensitization of hippocampal kainate receptors, J Neurosci, 17, 2713, 10.1523/JNEUROSCI.17-08-02713.1997

10.1523/JNEUROSCI.2826-05.2005

10.1176/appi.ajp.2007.07050776

10.1016/j.neulet.2008.03.029

Williams, 1993, Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors, Mol Pharmacol, 44, 851

Williams, 1993, Subunit-specific potentiation of recombinant N-methyl-d-aspartate receptors by histamine, Mol Pharmacol, 46, 531

10.1016/S0304-3940(96)12924-4

10.1042/bj3250289

Williams, 1996, Activation of N-methyl-d-aspartate receptors by glycine: role of an aspartate residue in the M3–M4 loop of the NR1 subunit, Mol Pharmacol, 50, 701

10.1124/jpet.102.045799

Williams, 1995, An acidic amino acid in the N-methyl-d-aspartate receptor that is important for spermine stimulation, Mol Pharmacol, 48, 1087

Williams, 1998, The selectivity filter of the N-methyl-d-aspartate receptor: a tryptophan residue controls block and permeation of Mg2+, Mol Pharmacol, 53, 933

Williams, 1994, Sensitivity of the N-methyl-d-aspartate receptor to polyamines is controlled by NR2 subunits, Mol Pharmacol, 45, 803

10.1016/j.bcp.2009.06.108

10.1159/000102568

10.1016/S0028-3908(01)00112-5

10.1016/0166-2236(95)93895-5

10.2165/00023210-200620030-00003

Wollmuth, 2000, The lurcher mutation identifies delta 2 as an AMPA/kainate receptor-like channel that is potentiated by Ca2+, J Neurosci, 20, 5973, 10.1523/JNEUROSCI.20-16-05973.2000

10.1113/jphysiol.1996.sp021257

10.1085/jgp.112.5.623

10.1016/j.tins.2004.04.005

10.1007/s12035-007-0038-6

10.1073/pnas.96.23.13409

10.1111/j.1742-4658.2008.06515.x

10.1523/JNEUROSCI.0284-07.2007

10.1016/0304-3940(88)90362-X

Wong, 1993, Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid- and kainate-preferring glutamate receptors, Mol Pharmacol, 44, 504

Wong, 1994, Willardiines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons, J Neurosci, 14, 3881, 10.1523/JNEUROSCI.14-06-03881.1994

10.1016/S0306-4522(97)00432-6

10.1016/S0042-6989(98)00001-7

Wong-Riley, 2002, AMPA glutamate receptor subunit 2 in normal and visually deprived macaque visual cortex, Vis Neurosci, 19, 563, 10.1017/S0952523802195022

10.1073/pnas.92.11.4882

10.1074/jbc.271.14.8115

10.1021/pr060016+

Woodward, 1995, In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-d-aspartate receptor glycine sites, Mol Pharmacol, 47, 568

Woodward, 1995, Pharmacology of 5-chloro-7-trifluoromethyl-1,4-dihydro-2,3-quinoxalinedione: a novel systemically active ionotropic glutamate receptor antagonist, J Pharmacol Exp Ther, 275, 1209

10.1126/science.288.5472.1765

10.1016/0304-3959(91)90100-C

10.1021/jm000023o

Wu CS Lu Y-J Li H-P Hsueh C Lu C-Y Leu Y-W Liu H-P Lin K-H Huang TH-M Chang Y-S (2010) Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer. Intl J Cancer in press.

Wu, 1991, Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-d-aspartate receptor, Mol Pharmacol, 40, 333

10.1016/j.nurt.2009.07.008

Wu, 1997, Potentiation of NMDA currents by pituitary adenylate cyclase activating polypeptide in neonatal rat sympathetic preganglionic neurons, J Neurophysiol, 78, 1175, 10.1152/jn.1997.78.2.1175

10.1111/j.1469-7793.1998.001bz.x

10.1098/rspb.1996.0159

10.1038/385439a0

Wyszynski, 1999, Association of AMPA receptors with a subset of glutamate receptor-interacting protein in vivo, J Neurosci, 19, 6528, 10.1523/JNEUROSCI.19-15-06528.1999

10.1016/S0896-6273(00)80689-3

10.1111/j.1460-9568.2005.03888.x

Xiong, 1999, Src potentiation of NMDA receptors in hippocampal and spinal neurons is not mediated by reducing zinc inhibition, J Neurosci, 19, RC37, 10.1523/JNEUROSCI.19-21-j0003.1999

10.1038/jcbfm.1994.32

10.1016/S0006-8993(98)00644-1

10.1074/jbc.M209141200

10.1073/pnas.062046299

10.1097/00001756-199306000-00021

10.1016/S0301-0082(99)00007-6

10.1016/j.biopsych.2005.03.018

Yamada, 1993, Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents, J Neurosci, 13, 3904, 10.1523/JNEUROSCI.13-09-03904.1993

Yamada, 1996, Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists, Br J Pharmacol, 117, 1663, 10.1111/j.1476-5381.1996.tb15337.x

10.1016/0014-5793(92)80160-I

10.1016/j.neures.2004.10.002

10.1016/j.pharmthera.2008.08.004

10.1002/hipo.20559

10.1046/j.1471-4159.2001.00255.x

10.1016/j.neuroscience.2006.04.063

10.1523/JNEUROSCI.0560-06.2006

10.1038/emboj.2008.140

10.1016/S1044-7431(03)00164-7

10.1016/S0006-291X(03)00070-6

10.1523/JNEUROSCI.4183-05.2006

10.1523/JNEUROSCI.4258-08.2008

10.1038/nature00978

10.1523/JNEUROSCI.0757-04.2004

10.1016/S0955-0674(00)00228-3

10.1385/MN:33:1:063

10.1038/24877

10.1073/pnas.96.14.7697

10.1006/nbdi.2002.0530

10.1074/jbc.M414215200

10.1523/JNEUROSCI.1365-09.2009

10.1074/jbc.M805123200

10.1016/0922-4106(95)90062-4

10.1016/S0896-6273(02)00861-9

10.1113/jphysiol.2006.122754

10.1089/neu.2005.22.1428

Yuzaki, 1999, Characterization of L-homocysteate-induced currents in Purkinje cells from wild-type and NMDA receptor knockout mice, J Neurophysiol, 82, 2820, 10.1152/jn.1999.82.5.2820

10.1126/science.284.5421.1805

10.1001/archpsyc.63.8.856

10.1176/appi.ajp.163.1.153

10.1085/jgp.103.2.231

Zarei, 1995, Structural basis for explaining open-channel blockade of the NMDA receptor, J Neurosci, 15, 1446, 10.1523/JNEUROSCI.15-02-01446.1995

Zhang, 2002, Suppression by zinc of AMPA receptor-mediated synaptic transmission in the retina, J Neurophysiol, 88, 1245, 10.1152/jn.2002.88.3.1245

10.1113/jphysiol.2009.168757

10.1016/j.neuropharm.2009.07.019

Zhang, 1997, Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations, J Neurophysiol, 78, 582, 10.1152/jn.1997.78.2.582

10.1523/JNEUROSCI.3309-07.2008

10.1038/nn.2214

10.1529/biophysj.106.084426

10.1016/j.neuron.2008.12.014

10.1016/j.brainres.2009.07.104

10.1124/mol.108.048819

10.1523/JNEUROSCI.2750-06.2006

10.1038/nn0901-894

10.1038/634

10.1016/0896-6273(94)90334-4

10.1073/pnas.0504612103

Zhou, 1997, (2S,4R)-4-methylglutamic acid (SYM 2081): a selective, high-affinity ligand for kainate receptors, J Pharmacol Exp Ther, 280, 422

10.1523/JNEUROSCI.4299-05.2006

10.1038/35102009

10.1038/80614

10.1085/jgp.117.3.287

10.1085/jgp.117.3.275

10.1016/0378-1119(95)00044-7

10.1038/42009